Navigation Links
New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
Date:2/14/2012

cessary to determine if angiogenesis-blocking drugs are particularly effective in patients with the angiogenic subtype. But there is reason for optimism: about 30 percent of serous ovarian cancer patients who receive angiogenesis inhibitors in a clinical trial benefit from the drugs; and the angiogenic subtype comprises about 30 percent of all serous ovarian cancers. "It is a test like this that may in the future help us select which patients will benefit most from a drug like Avastin," says Matulonis.

The researchers believe that their classification of this new subtype has great potential to influence the treatment many patients receive and improve outcomes for a significant number of people with this disease. "The approach we've taken in this study offers a powerful way of identifying molecular subtypes of other cancers as well," says Quackenbush.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Medusa-structure of gene regulatory network: Dominance of transcription factors in cancer subtypes
2. GW researchers reveal 18 novel subtype-dependent genetic variants for autism spectrum disorders and identify potential genetic markers for diagnostic screening
3. Different origins discovered for medulloblastoma tumor subtypes
4. Decreased survival for Puerto Rican women with triple-negative breast cancer subtype
5. New subtype of breast cancer responds to targeted drug
6. Faulty proteins may prove significant in identifying new treatments for ovarian cancer
7. Fat cells in abdomen fuel spread of ovarian cancer
8. Purdue technology used in first fluorescence-guided ovarian cancer surgery
9. Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds
10. Low dose naltrexone (LDN): Harnessing the bodys own chemistry to treat human ovarian cancer
11. University of Houston researcher an author of multi-institutional genetic study of ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/19/2015)... OXFORD, Conn. , March 19, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce market, ... featured in a news clip that aired this week on ... http://www.myfoxdc.com/ ) . In a segment "The Next ... smart wallet ,a new way to pay, and ,a really ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... the National Science Foundation (NSF) totaling $3.4 million, the ... will add 300 teraflops to the TeraGrid,s total computational ... more than 200 million additional service units, or CPU ... to over 800 million and benefitting the organization,s entire ...
... with cooperation partners from the U.S., the researchers surrounding Prof. ... their discovery in a so-termed Rapid Communication in the prestigious ... Society (JACS). The journal,s independent reviewers evaluated the work ... Better than household antifreeze Temperatures of minus ...
... pollute our environment with a number of heavy metals ... alone, an estimated 70% of heavy metals in landfill ... bigger and cheaper every year, environmental costs continue to ... Aviv University solution applies a discovery in nano-technology, based ...
Cached Biology News:NICS to add more than 300 Teraflops to the NSF’s computing capacity 2Why fish don't freeze in the Arctic Ocean 2'Greening' your flat screen TV 2
(Date:4/21/2015)... April 21, 2015 Progyny, Inc., the ... LLC, announced that it has secured additional capital from ... Biotech, SR One and Merck Serono Ventures. The funding ... patients the best fertility outcomes by aligning science, technology, ... online marketplace for families seeking fertility solutions and we ...
(Date:4/21/2015)... April 21, 2015 YourEncore, an ... life sciences, consumer products and food sciences industries ... the Alliance for Clinical Research Excellence and Safety ... for conducting clinical research, have partnered to speed ... , YourEncore brings to ACRES experts with ...
(Date:4/20/2015)... Texas , April 20, 2015 ... surgeons for healing bone injuries. The orthobiologics market is ... opportunities for its stakeholders. The global orthobiologics market report ... forecast of revenue. The global orthobiologics market was valued ... reach $7,900.2 million by 2019, at a CAGR of ...
(Date:4/20/2015)... , April 20, 2015  "Everybody is affected ... do to patients is frankly brutal. We,ve got to ... a cancer ward, or witnessed a loved one or ... witnessed firsthand the devastation chemotherapy and other treatments cause ... people want to give up and succumb to the ...
Breaking Biology Technology:Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2
... Calif., July 28, 2011 Life Technologies Corporation (NASDAQ: ... ending June 30, 2011. Non-GAAP revenue for the second quarter ... $906 million reported for the second quarter of 2010. Excluding ... 3 percent compared to the same period prior year. ...
... July 27, 2011 SomaLogic, Inc. and ... that they have entered into an exclusive ... SOMAmers as critical and unique reagents in ... amplification and polymerase chain reaction (PCR) products. ...
... routinely discarded during the birth process, a newborn,s umbilical ... that can be collected and stored for future medical ... potential, published data shows that three out of four ... banking. In connection with Cord Blood Awareness ...
Cached Biology Technology:Life Technologies Announces Second Quarter 2011 Results 2Life Technologies Announces Second Quarter 2011 Results 3Life Technologies Announces Second Quarter 2011 Results 4Life Technologies Announces Second Quarter 2011 Results 5Life Technologies Announces Second Quarter 2011 Results 6Life Technologies Announces Second Quarter 2011 Results 7Life Technologies Announces Second Quarter 2011 Results 8Life Technologies Announces Second Quarter 2011 Results 9Life Technologies Announces Second Quarter 2011 Results 10Life Technologies Announces Second Quarter 2011 Results 11Life Technologies Announces Second Quarter 2011 Results 12Life Technologies Announces Second Quarter 2011 Results 13Life Technologies Announces Second Quarter 2011 Results 14Life Technologies Announces Second Quarter 2011 Results 15Life Technologies Announces Second Quarter 2011 Results 16Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products 2Parent's Guide to Cord Blood Foundation Launches Nation's First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood 2Parent's Guide to Cord Blood Foundation Launches Nation's First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood 3
... Glutamate receptors constitute the principal ... Two classes of glutamate receptors ... receptors. Ionotropic glutamate receptors are ... (GluR1-7, NMDA1-3, KAI-2) which comprise ...
Recommended fro Western blotting application...
... 15 (KLF15) KLF15 is a Cys2-His2 ... expressed in the liver, kidneys, heart, and ... Specificity: Polyclonal antibody produced in rabbits immunized ... region of human KLF15 with an internal ...
... was developed in the late 1960s by ... the earliest commercial pioneers of immunoassay in ... in 1987. Sac-Cel rapidly found favour with ... "in house" radioimmunoassays, and became a benchmark ...
Biology Products: